Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Effects of endogenous sex hormones on lung function and symptom control in adolescents with asthma.

DeBoer MD, Phillips BR, Mauger DT, Zein J, Erzurum SC, Fitzpatrick AM, Gaston BM, Myers R, Ross KR, Chmiel J, Lee MJ, Fahy JV, Peters M, Ly NP, Wenzel SE, Fajt ML, Holguin F, Moore WC, Peters SP, Meyers D, Bleecker ER, Castro M, Coverstone AM, Bacharier LB, Jarjour NN, Sorkness RL, Ramratnam S, Irani AM, Israel E, Levy B, Phipatanakul W, Gaffin JM, Gerald Teague W.

BMC Pulm Med. 2018 Apr 10;18(1):58. doi: 10.1186/s12890-018-0612-x.

2.

Mastocytosis in Children.

Klaiber N, Kumar S, Irani AM.

Curr Allergy Asthma Rep. 2017 Oct 7;17(11):80. doi: 10.1007/s11882-017-0748-4. Review.

PMID:
28988349
3.

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Teague WG, Phillips BR, Fahy JV, Wenzel SE, Fitzpatrick AM, Moore WC, Hastie AT, Bleecker ER, Meyers DA, Peters SP, Castro M, Coverstone AM, Bacharier LB, Ly NP, Peters MC, Denlinger LC, Ramratnam S, Sorkness RL, Gaston BM, Erzurum SC, Comhair SAA, Myers RE, Zein J, DeBoer MD, Irani AM, Israel E, Levy B, Cardet JC, Phipatanakul W, Gaffin JM, Holguin F, Fajt ML, Aujla SJ, Mauger DT, Jarjour NN.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.

4.

Future Prospects of Biologic Therapies for Immunologic Diseases.

Kumar S, Ward BR, Irani AM.

Immunol Allergy Clin North Am. 2017 May;37(2):431-448. doi: 10.1016/j.iac.2017.01.013. Review.

PMID:
28366486
5.

Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.

Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, Bacharier LB, Bleecker ER, Comhair SA, Coverstone A, DeBoer M, Erzurum SC, Fain SB, Fajt M, Fitzpatrick AM, Gaffin J, Gaston B, Hastie AT, Hawkins GA, Holguin F, Irani AM, Israel E, Levy BD, Ly N, Meyers DA, Moore WC, Myers R, Opina MT, Peters MC, Schiebler ML, Sorkness RL, Teague WG, Wenzel SE, Woodruff PG, Mauger DT, Fahy JV, Jarjour NN; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):302-313. doi: 10.1164/rccm.201602-0419OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 1;197(7):971.

6.

Management and Prevention of Anaphylaxis.

Irani AM, Akl EG.

F1000Res. 2015 Dec 22;4. pii: F1000 Faculty Rev-1492. doi: 10.12688/f1000research.7181.1. eCollection 2015. Review.

7.

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M.

World Allergy Organ J. 2016 Feb 11;9:7. doi: 10.1186/s40413-016-0094-3. eCollection 2016. Review.

8.

Increased B Cell ADAM10 in Allergic Patients and Th2 Prone Mice.

Cooley LF, Martin RK, Zellner HB, Irani AM, Uram-Tuculescu C, El Shikh ME, Conrad DH.

PLoS One. 2015 May 1;10(5):e0124331. doi: 10.1371/journal.pone.0124331. eCollection 2015.

9.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results From the 2005-2006 National Health and Nutrition Examination Survey.

Irani AM.

Pediatrics. 2014 Nov;134 Suppl 3:S168. doi: 10.1542/peds.2014-1817HHH. No abstract available.

PMID:
25363967
10.

Food allergy and increased asthma morbidity in a school-based inner-city asthma study.

Irani AM.

Pediatrics. 2014 Nov;134 Suppl 3:S166-7. doi: 10.1542/peds.2014-1817EEE. No abstract available.

PMID:
25363964
11.

Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells.

Martin RK, Saleem SJ, Folgosa L, Zellner HB, Damle SR, Nguyen GK, Ryan JJ, Bear HD, Irani AM, Conrad DH.

J Leukoc Biol. 2014 Jul;96(1):151-9. doi: 10.1189/jlb.5A1213-644R. Epub 2014 Mar 7.

12.

Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis.

Dellon ES, Irani AM, Hill MR, Hirano I.

Aliment Pharmacol Ther. 2013 Sep;38(6):634-42. doi: 10.1111/apt.12413. Epub 2013 Jul 9.

13.

Evaluation of a practice-based intervention to improve the management of pediatric asthma.

Ragazzi H, Keller A, Ehrensberger R, Irani AM.

J Urban Health. 2011 Feb;88 Suppl 1:38-48. doi: 10.1007/s11524-010-9471-3.

14.

Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease.

Wasserman RL, Irani AM, Tracy J, Tsoukas C, Stark D, Levy R, Chen J, Sorrells S, Roberts R, Gupta S.

Clin Exp Immunol. 2010 Sep;161(3):518-26. doi: 10.1111/j.1365-2249.2010.04195.x.

15.

A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysis.

Sábato MF, Irani AM, Bukaveckas BL, Schwartz LB, Wilkinson DS, Ferreira-Gonzalez A.

J Mol Diagn. 2008 May;10(3):258-64. doi: 10.2353/jmoldx.2008.070133.

16.

Ocular mast cells and mediators.

Irani AM.

Immunol Allergy Clin North Am. 2008 Feb;28(1):25-42, v. doi: 10.1016/j.iac.2007.12.006. Review.

PMID:
18282544
17.

Treatment of eosinophilic esophagitis with inhaled budesonide in a 7-year-old boy with concomitant persistent asthma: resolution of esophageal submucosal fibrosis and eosinophilic infiltration.

Maples KM, Henderson SC, Graham M, Irani AM.

Ann Allergy Asthma Immunol. 2007 Dec;99(6):572-4. doi: 10.1016/S1081-1206(10)60390-0. No abstract available.

PMID:
18219842
18.

Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus.

Garfield RE, Irani AM, Schwartz LB, Bytautiene E, Romero R.

Am J Obstet Gynecol. 2006 Jan;194(1):261-7.

PMID:
16389041
19.

The challenge of mild persistent asthma.

Irani AM.

Ann Allergy Asthma Immunol. 2005 May;94(5):517-27; quiz 527-9, 574. Review.

PMID:
15945553
20.

Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze.

Berger WE, Qaqundah PY, Blake K, Rodriguez-Santana J, Irani AM, Xu J, Goldman M.

J Pediatr. 2005 Jan;146(1):91-5.

PMID:
15644830
21.

Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.

Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM.

Ann Allergy Asthma Immunol. 2003 Jul;91(1):49-54.

PMID:
12877449
22.

Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin.

Cooper PJ, Schwartz LB, Irani AM, Awadzi K, Guderian RH, Nutman TB.

J Infect Dis. 2002 Nov 1;186(9):1307-13. Epub 2002 Oct 11.

PMID:
12402200
23.

Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.

Irani AM, Cruz-Rivera M, Fitzpatrick S, Hoag J, Smith JA.

Ann Allergy Asthma Immunol. 2002 Mar;88(3):306-12.

PMID:
11926625
24.

Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.

Wilson DR, Irani AM, Walker SM, Jacobson MR, Mackay IS, Schwartz LB, Durham SR.

Clin Exp Allergy. 2001 Nov;31(11):1705-13.

PMID:
11696046
25.

Basophil recruitment and IL-4 production during human allergen-induced late asthma.

Nouri-Aria KT, Irani AM, Jacobson MR, O'brien F, Varga EM, Till SJ, Durham SR, Schwartz LB.

J Allergy Clin Immunol. 2001 Aug;108(2):205-11.

PMID:
11496235
26.

Disialoganglioside GD3 is selectively expressed by developing and mature human mast cells.

Ren S, Kambe N, Du Z, Li Y, Xia HZ, Kambe M, Bieberich E, Pozez A, Grimes M, Yu RK, Irani AM, Schwartz LB.

J Allergy Clin Immunol. 2001 Feb;107(2):322-30.

PMID:
11174200
27.

Tear and conjunctival changes during the allergen-induced early- and late-phase responses.

Bacon AS, Ahluwalia P, Irani AM, Schwartz LB, Holgate ST, Church MK, McGill JI.

J Allergy Clin Immunol. 2000 Nov;106(5):948-54.

PMID:
11080719
28.

Serum tryptase and the laboratory diagnosis of systemic mastocytosis.

Schwartz LB, Irani AM.

Hematol Oncol Clin North Am. 2000 Jun;14(3):641-57. Review.

PMID:
10909044
29.

Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics.

Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwartz LB, O'Byrne PM.

Am J Respir Crit Care Med. 2000 May;161(5):1473-8.

PMID:
10806141
30.

The potential clinical utility of serum alpha-protryptase levels.

Kanthawatana S, Carias K, Arnaout R, Hu J, Irani AM, Schwartz LB.

J Allergy Clin Immunol. 1999 Jun;103(6):1092-9.

PMID:
10359891
31.

Immunohistochemical detection of human basophils in late-phase skin reactions.

Irani AM, Huang C, Xia HZ, Kepley C, Nafie A, Fouda ED, Craig S, Zweiman B, Schwartz LB.

J Allergy Clin Immunol. 1998 Mar;101(3):354-62.

PMID:
9525452
32.

Apnea as a manifestation of mast cell activation in an infant with mastocytosis.

Arnaout RK, Schwartz LB, Irani AM.

J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):850-1. No abstract available.

PMID:
9438498
33.

Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.

Xia HZ, Du Z, Craig S, Klisch G, Noben-Trauth N, Kochan JP, Huff TH, Irani AM, Schwartz LB.

J Immunol. 1997 Sep 15;159(6):2911-21.

PMID:
9300715
35.
36.
37.

Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils.

Craig SS, Krishnaswamy P, Irani AM, Kepley CL, Liu FT, Schwartz LB.

Anat Rec. 1995 Jun;242(2):211-9.

PMID:
7668406
38.
39.

Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects.

Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV.

J Allergy Clin Immunol. 1995 Mar;95(3):716-25.

PMID:
7897155
40.

Human mast cell heterogeneity.

Irani AM, Schwartz LB.

Allergy Proc. 1994 Nov-Dec;15(6):303-8. Review.

PMID:
7721078
41.

Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells.

Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani AM, Schwartz LB.

Blood. 1994 Sep 1;84(5):1519-27.

PMID:
7520776
42.

Involvement of mast cells in sudden infant death syndrome.

Platt MS, Yunginger JW, Sekula-Perlman A, Irani AM, Smialek J, Mirchandani HG, Schwartz LB.

J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):250-6.

PMID:
8064077
43.

Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, Van der Linden PW.

J Clin Immunol. 1994 May;14(3):190-204.

PMID:
7929694
44.

Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold.

Craig SS, Irani AM, Metcalfe DD, Schwartz LB.

Lab Invest. 1993 Nov;69(5):552-61.

PMID:
8246447
45.

Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells.

Nilsson G, Forsberg K, Bodger MP, Ashman LK, Zsebo KM, Ishizaka T, Irani AM, Schwartz LB.

Immunology. 1993 Jun;79(2):325-30.

46.

Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand.

Mitsui H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N, Takei M, Ishizaka K, Zsebo KM, Gillis S, et al.

Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):735-9.

47.

Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.

Irani AM, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwartz LB.

Blood. 1992 Dec 15;80(12):3009-21.

PMID:
1281684
48.

Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.

Irani AM, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB.

Arthritis Rheum. 1992 Aug;35(8):933-9.

PMID:
1642658
49.

Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils.

Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AM, Schwartz LB, Mackay IS, Kay AB, Durham SR.

Am Rev Respir Dis. 1992 Jul;146(1):170-6.

PMID:
1626799
50.

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells.

Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB, Irani AM, Kay AB, Durham SR.

J Allergy Clin Immunol. 1992 Apr;89(4):877-83.

PMID:
1532808

Supplemental Content

Loading ...
Support Center